News and Trends 22 Apr 2022
European Biotech Investors Brace for Volatility in 2022
After gathering huge investment funds in 2021, European biotech investors took a breather in the first quarter of 2022, with…
Lundbeck
- Latest Posts
Interview 20 Nov 2018
Why Denmark Is a Strong Player in Europe’s Biotech Industry
Denmark is a rapidly growing hotspot for biotech. During the BIO-Europe conference in Copenhagen, I talked to Mette Kirstine Agger,…
News and Trends 16 Mar 2018
Lundbeck Signs Near €1Bn Acquisition of Swiss Parkinson’s Biotech
Lundbeck is acquiring Prexton Therapeutics in a deal that could reach up to €905M if the Swiss company's Parkinson's treatment…
News and Trends 26 Sep 2017
Belgian Biotech Teams Up With Lundbeck to Collaborate on Drug Discovery
Confo and Lundbeck have joined forces to push through drug discovery against a tough-to-target protein using Confo's special technology. Confo Therapeutics develops small…
ADVERTISEMENT
More News! 21 Jun 2017
Swedish IPO raises €51M for Biomaterials to Repair Bone
Bonesupport has gone public in the Swedish stock market to push its pipeline and increase sales of biomaterials to regenerate bone…
News and Trends 30 Jan 2017
‘Trojan Horse’ Shark Antibodies could beat the Blood Brain Barrier
Ossianix, partnered with Lundbeck, is developing shark antibodies that can help therapeutics cross the blood brain barrier. Ossianix develops shark-inspired…
News and Trends 20 Aug 2015
Lundbeck dismisses 1,000 employees to stay competitive
Lundbeck's new CEO Kåre Schultz completely restructures the company to regain profitability. About 1/6th of the company's employees will have to leave…